Alkylating Agents in Pancreatic Neuroendocrine Tumors OncLive To investigate this further, an ongoing phase II study investigating the effectiveness of everolimus in patients with pNETs following the surgical resection of liver metastases is enrolling patients with results expected in 2-3 years (NCT02031536). A ... |
